Summary by Moomoo AI
Illumina announced it will recognize significant impairment charges in the second quarter of 2024 following an impairment test of GRAIL-related assets. The company estimates a goodwill impairment charge of $1,466 million, representing the full remaining carrying value of GRAIL's goodwill as of March 31, 2024.Additionally, Illumina will record a $420 million impairment charge for GRAIL's in-process research and development (IPR&D) intangible asset. The company stated these charges will be excluded from non-GAAP financial metrics and are not expected to result in any material future cash expenditures.